Groups | Variable | OR | 95% CI | P value |
Subgroup 1 | Age | 1.055 | 1.027 to 1.083 | <0.001* |
SII | 1.303 | 1.102 to 1.501 | 0.011* | |
Coma | 2.726 | 1.547 to 3.963 | 0.026* | |
Straight sinus | 2.485 | 1.142 to 5.409 | 0.022* | |
Subgroup 2 | Age | 1.100 | 1.027 to 1.177 | 0.006* |
SII | 1.104 | 0.998 to 1.209 | 0.251 | |
Coma | 2.667 | 1.196 to 5.209 | 0.001* | |
Straight sinus | 5.104 | 1.998 to 12.209 | 0.009* | |
Subgroup 3 | Age | 1.216 | 0.862 to 1.715 | 0.266 |
SII | 1.407 | 1.204 to 1.703 | 0.034* | |
Coma | 1.101 | 0.997 to 1.501 | 0.061 | |
Straight sinus | 5.412 | 0.769 to 11.436 | 0.120 | |
Subgroup 4 | Age | 1.064 | 1.016 to 1.115 | 0.009* |
SII | 1.207 | 0.986 to 1.505 | 0.119 | |
Coma | 4.753 | 2.082 to 6.834 | 0.003* | |
Straight sinus | 4.086 | 1.031 to 8.696 | 0.046* |
*Statistically significant. Subgroup analysis was carried out in male (subgroup 1), female (subgroup 2), pregnancy/puerperium (subgroup 3) and non-pregnancy/puerperium (subgroup 4) Patients with CVST.
CVST, cerebral venous sinus thrombosis; SII, systemic immune–inflammation index.